EP2506726A1 - Composition acting as an emulsifier for water-soluble solubilisates of hydrophobic compounds - Google Patents

Composition acting as an emulsifier for water-soluble solubilisates of hydrophobic compounds

Info

Publication number
EP2506726A1
EP2506726A1 EP10785350A EP10785350A EP2506726A1 EP 2506726 A1 EP2506726 A1 EP 2506726A1 EP 10785350 A EP10785350 A EP 10785350A EP 10785350 A EP10785350 A EP 10785350A EP 2506726 A1 EP2506726 A1 EP 2506726A1
Authority
EP
European Patent Office
Prior art keywords
sucrose
soluble
water
emulsifier
hydrophobic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10785350A
Other languages
German (de)
French (fr)
Inventor
Dariush Behnam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aquanova AG
Original Assignee
Aquanova AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aquanova AG filed Critical Aquanova AG
Publication of EP2506726A1 publication Critical patent/EP2506726A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01Other fatty acid esters, e.g. phosphatides
    • A23D7/011Compositions other than spreads
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/10Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • A23L33/155Vitamins A or D
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/065Diphenyl-substituted acyclic alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/121Ketones acyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5929,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • A61K8/355Quinones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials

Definitions

  • Emulsifying composition for water-soluble solubilisates of hydrophobic compounds Emulsifying composition for water-soluble solubilisates of hydrophobic compounds
  • Body cell (6) shown schematically.
  • Step 1 Formation and reception of
  • Lipophilic micronutrients such as vitamins A, D, E and K, but also carotenoids, omega-3 fatty acids, alpha-lipoic acid and coenzyme Q10, etc.
  • hydrophobic compounds such as fat-soluble vitamins, various barriers of the intestinal mucosa can be overcome and absorbed.
  • the fat-soluble compounds such as vitamins A, D, E and K, omega-3 fatty acid, alpha-lipoic acid, coenzyme Q10, etc. are brought into a water-soluble packaging form and can only in the thin water film of the cell membranes The mucosal cells (3) of the small intestine penetrate and be absorbed.
  • This 1st step that is the icell mich of the lipophilic substances, is regarded as indispensable condition for the fat absorption and likewise as
  • Step 2 Free, fat-soluble micronutrients (10) are made water-soluble by means of lipoprotein chylomircones and are thus removed from the lymphatic system (4).
  • the fat-soluble micronutrients After the absorption of the fat-soluble micronutrients in the cells of the small intestine they are there free and not in micellar bound form.
  • the fat-soluble ones can also be used.
  • Packaging like the micelle are absorbed.
  • FIG. 2 schematically shows on the left a conventional fine emulsion in aqueous solution and in the middle a micellar solution.
  • the conventional fine emulsion in aqueous solution is cloudy and unstable, the
  • micellar solution is clear and stable, the absorption occurs without the physiological micelle formation.
  • FIG. 3 shows photographic images of conventional emulsions in aqueous solution.
  • 2.2 Micellar formulation in aqueous solution
  • FIG. 4 shows photographic images of micellar formulations in aqueous solution.
  • Carrier systems for fat-soluble substances :
  • FIG. 5 shows a comparison of AQUANOVA solubilisates with liposomes and conventional emulsions as a function of the particle size.
  • Aquanova solubilisates (20) are acid stable, no phase separation.
  • Nano / fine emulsions, v emulsions, liposomes (30) are acid unstable,
  • micellar formulations as
  • the invention is due to the mentioned in the above-mentioned position 3 serious disadvantages of polysorbate or lecithin-containing micelle formers, the object of proposing a natural analogous carrier system "product micelle", which at least partially the replacement of polysorbates and / or phospholipids allows the creation of product micelles and, when used, leads to solubilisates which are found in foods or
  • Nutritional supplements have the required thermal, pH and mechanical stability and whose product micelles so intact after oral ingestion reaches the mucosa cells of the small intestine, thus absorbing the trapped in the micelle
  • Vitamins such as vitamins A, D, E and K, carotenoids, omega-3 fatty acids, alpha-lipoic acid and coenzyme Q10, to optimize.
  • sugar esters of fatty acids (E 473) and auxiliaries are used.
  • an emulator system by either individual sugar esters of fatty acids (E 473) or mixtures of at least two sugar esters of fatty acids, each in a
  • a composition combined with at least one further constituent, which carrier is at least one OH group, such as water and / or ethanol and / or Glycerol, are used as an emulsifier and are used in combination with polysorbates or in their place.
  • Suitable sugar esters of fatty acids are, in particular, sucrose mono-laurate, sucrose-di-laurate,
  • Fatty acids and a carrier of at least one OH group may further comprise at least one medium chain
  • Triglyceride (medium chain triglyceride, MCT).
  • the invention provides a composition having an HLB value greater than 10, which acts as an emulsifier for a solubilizate of at least one raw and / or active substance which is not or only sparingly soluble in water, and one or more sugar esters of a fatty acid (E 473) in combination with at least one constituent which is a carrier of at least one OH group, in particular water and / or ethanol and / or glycerol.
  • the composition may consist of one or more sugar esters of a fatty acid fatty acid (E 473) and at least one constituent which is a carrier of at least one OH group, in particular water and / or ethanol and / or glycerol.
  • the invention further provides a solubilizate which contains at least one raw and / or active substance which is insoluble or sparingly soluble in water, the raw and / or active substance being selected in particular from the coarse containing the vitamins A, D, E and K,
  • solubilizate contains at least one emulsifier-acting composition described above.
  • the solubilizate can in particular from the at least one raw and / or
  • Active substance which is insoluble or sparingly soluble in water, the raw and / or active substance being selected in particular from the coarse containing vitamins A, D, E and K, carotenoids, flavonoids, omega-3 fatty acids, enzymes, Coenzymes, dyes, plant extracts,
  • Secondary plant materials isoflavones
  • polyphenols polyphenols
  • essential oils and antioxidants such as alpha-lipoic acid and / or carnosic acid and quercetin, and at least one, as described above acting as an emulsifier composition.
  • compositions which act as emulsifier are, for example, the following, wherein in percent (%) the respective weight fraction is indicated:
  • Emulsifier Composition A Emulsifier Composition A
  • Emulsifier Composition B Emulsifier Composition B
  • Emulsifier composition C Emulsifier composition C
  • emulsifier compositions To prepare the emulsifier compositions, all components are mixed together at room temperature, stirred well and thereby homogenized. For support, a slight warming to, for example, about 48 ° C to 52 ° C can be performed.
  • an AGT material no. specified This is a test number that assigns the applicant for each substance used and on the basis of which the identity of the ingredient used in each case for the solubilizate can be traced. For these solubilisates were partially the
  • Vitamin E-Actetate Solubilisate (with Emulsifier B)
  • Particle size measurements were made with the ParticleMetrix NANOTRAC Backscatter Particle Analyzer.
  • the measuring principle is based on dynamic light scattering (DLS) in a 180 ° heterodyne backscatter arrangement. With this geometry, the scattered light becomes part of the
  • the laser light of a wavelength of 780 nm is coupled on one side of a light fiber fork:
  • the reflected laser light, irradiated together and reflected light (42) and the backscattered light (43) from the sample Both split evenly on the two light guide branches.
  • the detector (60) of the second branch of the optical fiber fork the mixed light, the scattered and reflected light (44) is registered.
  • Fluctuation of the signal resulting from the Brown's motion in the scattered light and thus in the overall signal is converted into a particle size distribution via the Stokes-Einstein relationship and a fast Fourier analysis.
  • the color of the sample does not affect the quality of the sample
  • the detectable particle size range extends from 0.8 nm to 6500 nm.
  • the measurements were carried out in 1000 times the aqueous dilution.
  • Solubilisate was dissolved with stirring in water. It is completely soluble in water. This solution is stable, transparent.
  • the turbidity of a sample is due to the fact that incident light is scattered on the suspended particles of undissolved, finely divided substances. If a straight light beam strikes these particles (50), the light is scattered in all directions. For turbidity measurement, a scattered light measurement was carried out with infrared light. At low turbidity levels, a small number of undissolved ingredients can be assumed.

Abstract

The invention relates to a composition having an HLB value greater than 10, which acts as an emulsifier for a solubilisate of at least one raw material and/or active substance which is insoluble or only soluble with difficulty in water, and one or more sucrose esters of an edible fatty acid (E473) in combination with at least one constituent which is a carrier of at least one OH group, in particular water and/or ethanol and/or glycerol.

Description

Als Emulgator wirkende Zusammensetzung für wasserlösliche Solubilisate hydrophober Verbindungen  Emulsifying composition for water-soluble solubilisates of hydrophobic compounds
BESCHREIBUNG: DESCRIPTION:
1. ) Fettabsorption Im Gegensatz zu den von Natur aus wasserlöslich vorliegenden Verbindungen, wie z.B. Ascorbinsäure und B-Vitamine, muss der menschliche Organismus, um lipophile Mikronährstoffe aufzunehmen, diese in zwei Schritten in eine wasserlösliche Verpackung überführen.  1.) Fat absorption In contrast to the naturally water-soluble compounds, e.g. Ascorbic acid and B vitamins, the human organism to take lipophilic micronutrients, it must be converted in two steps in a water-soluble packaging.
In Figur 1 ist die Absorption fettlöslicher Verbindungen wie Vitamin A, D, E und K (12) nach oraler Aufnahme (1) über Magen-Darm-Trakt (2) , Mukosazelle (3) , Lympfweg (4) und Blut (5) in eineIn Figure 1, the absorption of fat-soluble compounds such as vitamins A, D, E and K (12) after oral intake (1) via the gastrointestinal tract (2), mucosa cell (3), Lympfweg (4) and blood (5) in a
Körperzelle (6) schematisch dargestellt. Body cell (6) shown schematically.
1. Schritt (1) : Bildung und Aufnahme von Step 1 (1): Formation and reception of
physiologischen und/oder Produktmicellen (9)  physiological and / or product micelles (9)
Lipophile Mikronährstoffe , wie z.B. Vitamine A, D, E und K aber auch Carotinoide, Omega-3 -Fettsäuren, Alpha-Liponsäure und Coenzym Q10 usw. können fast ausschließlich mit Hilfe von Gallensalzen, Gallensäuren und den Enzymen der Bauchspeicheldrüse, die für die Bildung der so genanten physiologischen Micelle im Dünndarm unabdingbar sind, absorbiert werden. Nur auf dieser Weise, bzw. durch solche Verpackung, können hydrophobe Verbindungen, wie z.B. fettlösliche Vitamine, diverse Barrieren der Darmmukosa überwinden und absorbiert werden. Durch den Prozess der Micellenbildung werden die fettlöslichen Verbindungen, wie die Vitamine A, D, E und K, Omega-3 -Fettsäure, Alpha-Liponsäure , Coenzym Q10 usw. in eine wasserlösliche Verpackungsform gebracht und können nur so in den dünnen Wasserfilm der Zellmembranen der Mukosazellen (3) des Dünndarms eindringen und aufgenommen werden. Lipophilic micronutrients, such as vitamins A, D, E and K, but also carotenoids, omega-3 fatty acids, alpha-lipoic acid and coenzyme Q10, etc., can be produced almost exclusively with the help of bile salts, bile acids and the enzymes of the pancreas, which are indispensable for the formation of the so-called physiological micelle in the small intestine. Only in this way, or by such packaging, hydrophobic compounds, such as fat-soluble vitamins, various barriers of the intestinal mucosa can be overcome and absorbed. Through the process of micelle formation, the fat-soluble compounds, such as vitamins A, D, E and K, omega-3 fatty acid, alpha-lipoic acid, coenzyme Q10, etc. are brought into a water-soluble packaging form and can only in the thin water film of the cell membranes The mucosal cells (3) of the small intestine penetrate and be absorbed.
Dieser 1. Schritt; das heißt die icellierung der lipophilen Substanzen, gilt als unverzichtbare Voraussetzung für die Fettabsorption und ebenso alsThis 1st step; that is the icellierung of the lipophilic substances, is regarded as indispensable condition for the fat absorption and likewise as
Voraussetzung für den nachfolgenden 2. Schritt. Prerequisite for the following 2nd step.
2. Schritt (8): Freie, fettlösliche Mikronährstoffe (10) werden mit Hilfe von Lipoprotein-Chylomirkonen wasserlöslich gemacht und so vom Lymphweg (4) Step 2 (8): Free, fat-soluble micronutrients (10) are made water-soluble by means of lipoprotein chylomircones and are thus removed from the lymphatic system (4).
aufgenommen recorded
Nach der Aufnahme der fettlöslichen Mikronährstoffe in die Zellen des Dünndarms liegen diese dort frei und nicht in micellar gebundener Form vor. Hier werden die fettlöslichen Mikronährstoffe , um in das Blut (5) abgegeben werden zu können, durch die in den Darmzellen gebildeten Transporter „Lypoproteine- Chylomikronen" erneut wasserlöslich gemacht. After the absorption of the fat-soluble micronutrients in the cells of the small intestine they are there free and not in micellar bound form. Here, the fat-soluble micronutrients to be delivered into the blood (5) through which in the Intestinal cells formed transporter "Lypoproteine- Chylomikronen" again made water soluble.
Fazit : Conclusion :
Wie die schon von Natur aus in wasserlöslicher Form vorliegenden Verbindungen, wie Vitamin C und B- Vitamine, können auch die fettlöslichen  Like the compounds that are naturally present in water-soluble form, such as vitamin C and B vitamins, the fat-soluble ones can also be used
Mikronährstoffe erst durch eine wasserlösliche  Micronutrients first through a water-soluble
Verpackung wie die Micelle absorbiert werden.  Packaging like the micelle are absorbed.
In Figur 2 sind schematisch links eine herkömmliche Feinemulsion in wässriger Lösung und in der Mitte eine micellare Lösung gezeigt. Die herkömmliche Feinemulsion in wässriger Lösung ist trüb und instabil, die FIG. 2 schematically shows on the left a conventional fine emulsion in aqueous solution and in the middle a micellar solution. The conventional fine emulsion in aqueous solution is cloudy and unstable, the
Absorption erfolgt nur mit Hilfe der physiologischen Absorption takes place only with the help of physiological
Micellenbildung . Die micellare Lösung ist klar und stabil, die Absorption erfolgt ohne die physiologische Micellenbildung . Eine Beurteilung der Rolle der Micelle als Naturprinzip und im Vergleich dazu der Rolle der von der Anmelderin Micelle formation. The micellar solution is clear and stable, the absorption occurs without the physiological micelle formation. An assessment of the role of the micelle as a natural principle and, in comparison, the role of the applicant
verwirklichten Produtmicelle (10) namhafter Wissenschafter wurde zusammen mit der Anmeldung zur Akte gereicht. 2.1 Herkömmliche Emulsion in wässriger Lösung Produtmicelle (10) of renowned scientists was presented together with the application for the file. 2.1 Conventional emulsion in aqueous solution
In Figur 3 sind fotografische Aufnahmen von herkömmlichen Emulsionen in wässriger Lösung gezeigt. 2.2 Micellare Formulierung in wässriger Lösung FIG. 3 shows photographic images of conventional emulsions in aqueous solution. 2.2 Micellar formulation in aqueous solution
In Figur 4 sind fotografische Aufnahmen von micellarer Formulierungen in wässriger Lösung gezeigt. 2.3 Trägersysteme für fettlösliche Substanzen: FIG. 4 shows photographic images of micellar formulations in aqueous solution. 2.3 Carrier systems for fat-soluble substances:
In Figur 5 ist ein Vergleich von AQUANOVA-Solubilisaten mit Liposomen und herkömmlichen Emulsionen in Abhängigkeit von der Partikelgröße gezeigt. Aquanova-Solubilisate (20) sind säurestabil, keine Phasentrennung. Nano- /Feinemulsionen, v Emulsionen, Liposome (30) sind säureinstabil, FIG. 5 shows a comparison of AQUANOVA solubilisates with liposomes and conventional emulsions as a function of the particle size. Aquanova solubilisates (20) are acid stable, no phase separation. Nano / fine emulsions, v emulsions, liposomes (30) are acid unstable,
Phasentrennung in sauren Milieu. Phase separation in an acidic environment.
AQUANOVA-Solubilisate Herkömmliche mit Emulsionen,AQUANOVA solubilisates Conventional with emulsions,
Micellencharakteristik Mikro- und Micellencharakteristik micro and
Nanoemulsionen nanoemulsions
Optik Vollständig und Wasserunlöslich irreversibel (trüb bis wasserlösliche , opalisierend in vollkommen transparent wässrigen in wässriger Lösung Medien) Optics Completely and water-insoluble irreversible (turbid to water-soluble, opalescent in completely transparent aqueous in aqueous solution media)
Stabilität Thermisch, mechanisch Thermisch,  Stability Thermal, Mechanical Thermal,
und magensäurestabil mechanisch unhd und mikrobiologisch magensäure- weniger anfällig instabil und mikrobiologisch anfällig  and gastric acid stable mechanically unhod and microbiologically gastric acid less susceptible to instability and microbiologically susceptible
Charakterisitk bei Höhere und schnellere Geringe und oraler Anwendung intestinale Resorption langsame  Characteristic for higher and faster low and oral application slow intestinal absorption
(Nahrung) (ohne Beteiligung der Resorption (mit (Food) (without involvement of absorption (with
Gallensäuren) Hilfe der  Bile acids) help the
Gallensäuren) Bile acids)
Charakteristik bei Höhere und schnellere Geringe und dermaler Anwendung Penetration langsame (Hautpflege) PenetrationCharacteristic for higher and faster low and dermal application penetration slow (Skin Care) Penetration
Einarbeitung in Optimale und direkte Aufwendige und Endprodukte Einarbeitung in teilweise Incorporation into optimal and direct laborious and end products training in partial
Endprodukte , problematische unabhängig von der Einarbeitung in Beschaffenheit des Endprodukte Endproduktes und ohne  End products, problematic regardless of the incorporation into the nature of the end product end product and without
Matrixdesign  matrix design
Beladungskapazität Micellen : 9200 nm3 Liposome : 5600 für Außennm3 Loading capacity of micelles: 9200 nm 3 Liposomes: 5600 for outer diameter 3
durchmesser = 30 diameter = 30
nm nm
Bisher bekannte micellare Formulierungen als Previously known micellar formulations as
TrägerSysteme :  Carrier systems:
Nicht zuletzt durch diverse Patentanmeldungen der Firma AQUANOVA ist bekannt, dass mit Hilfe von z.B. Polysorbaten Produktmicellen im Sinne dieser Anmeldung hergestellt werden können. Bekannt ist aber auch, dass die Polysorbate ein wesentliches sensorisches Problem in den betreffenden Produkten (Lebensmittel, Not least by various patent applications of the company AQUANOVA is known that with the aid of e.g. Polysorbates product micelles can be prepared in the context of this application. But it is also known that the polysorbates cause a significant sensory problem in the products in question (food,
Nahrungsergänzungsmittel) darstellen und darüber hinaus nur eingeschränkt zugelassen sind.  Dietary supplements) and are also only partially approved.
Es ist auch gelungen, mit Hilfe von Lecithin bzw. It was also possible with the help of lecithin or
Phospholipiden pseudo-micellare Strukturen zu  Phospholipids pseudo-micellar structures too
schaffen, die jedoch weder die nötige pH- oder  create, however, neither the necessary pH or
thermische, bzw. mechanische Stabilität aufweisen. Diese sind lediglich in wässrige Lösung bei  have thermal or mechanical stability. These are only included in aqueous solution
Raumtemperatur und im mittleren pH-Bereich relativ klar. Durch die beschriebene Instabilität dieser Art von Pseudomicellen, die im Magen-Darm-Trakt zerstört werden, können keine Vorteile und keine Optimierung der Fettabsorption erwartet werden. Room temperature and in the middle pH range relative clear. The described instability of this type of pseudomicella, which is destroyed in the gastrointestinal tract, no benefits and no optimization of fat absorption can be expected.
4.) Gegenstand der Erfindung: 4.) Object of the invention:
Der Erfindung liegt, auf Grund der in der oben genannten Position 3 genannten gravierenden Nachteile der polysorbat- bzw. lecithinhaltigen Micellenbildnern, die Aufgabe zu Grunde, ein naturanaloges Trägersystem „Produktmicelle" , vorzuschlagen, welches zumindest teilweise den Ersatz von Polysorbaten und/oder Phospholipiden bei der Schaffung von Produktmicellen erlaubt und bei Anwendung zu Solubilisaten führt, welche in Lebensmitteln oder The invention is due to the mentioned in the above-mentioned position 3 serious disadvantages of polysorbate or lecithin-containing micelle formers, the object of proposing a natural analogous carrier system "product micelle", which at least partially the replacement of polysorbates and / or phospholipids allows the creation of product micelles and, when used, leads to solubilisates which are found in foods or
Nahrungsergänzüngsmitteln die erforderliche thermische, pH- mäßige sowie mechanische Stabilität aufweisen und deren Produktmicellen so unbeschadet nach oraler Aufnahme die Mukosazellen des Dünndarms erreicht, um auf diese Weise die Absorption der in der Micelle eingeschlossenen  Nutritional supplements have the required thermal, pH and mechanical stability and whose product micelles so intact after oral ingestion reaches the mucosa cells of the small intestine, thus absorbing the trapped in the micelle
Mikronährstoffe , insbesondere die der fettlöslichen Micronutrients, especially those of the fat-soluble
Vitamine wie Vitamin A, D, E und K, Carotinoide, Omega-3- Fettsäure, Alpha-Liponsäure und Coenzym Q10, zu optimieren. Vitamins such as vitamins A, D, E and K, carotenoids, omega-3 fatty acids, alpha-lipoic acid and coenzyme Q10, to optimize.
Dazu werden Zuckerester von Speisefettsäuren (E 473) und Hilfsstoffe eingesetzt. Diese bilden gemäß der Erfindung ein Emulatorsystem, indem entweder einzelne Zuckerester von Speisefettsäuren (E 473) oder Mischungen von zumindest zwei Zuckerestern von Speisefettsäuren, jeweils in einer For this purpose, sugar esters of fatty acids (E 473) and auxiliaries are used. These form according to the invention, an emulator system by either individual sugar esters of fatty acids (E 473) or mixtures of at least two sugar esters of fatty acids, each in a
Zusammensetzung kombiniert mit wenigstens einem weiteren Bestandteil, welcher Träger mindestens einer OH-Gruppe ist, wie beispielsweise Wasser und/oder Ethanol und/oder Glycerin, als Emulgator eingesetzt werden und dabei in Kombination mit Polysorbaten oder an deren Stelle verwendet werden. Geeignete Zuckerester von Speisefettsäuren sind insbesondere Sucrose-mono-Laurat , Sucrose-di-Laurat , A composition combined with at least one further constituent, which carrier is at least one OH group, such as water and / or ethanol and / or Glycerol, are used as an emulsifier and are used in combination with polysorbates or in their place. Suitable sugar esters of fatty acids are, in particular, sucrose mono-laurate, sucrose-di-laurate,
Sucrose-mono-Palmitat , Sucrose-di-Palmitat , Sucrose-mono-Sucrose-mono-palmitate, sucrose-di-palmitate, sucrose-mono-
Stearat und Sucrose-di-Stearat . Der als Emulgator wirksamen Kombination aus zumindest einem Zuckerester aus Stearate and sucrose-di-stearate. The effective as an emulsifier combination of at least one sugar ester
Speisefettsäuren und einem Träger mindestens einer OH- Gruppe kann des Weiteren zumindest ein mittelkettiges Fatty acids and a carrier of at least one OH group may further comprise at least one medium chain
Triglycerid (medium chain triglyceride , MCT) beigegeben werden . Triglyceride (medium chain triglyceride, MCT).
Die Erfindung stellt eine Zusammensetzung zur Verfügung mit einem HLB-Wert von größer 10, welche als Emulgator für ein Solubilisat zumindest eines Roh- und/oder Wirkstoffes, welcher in Wasser nicht oder nur schwer löslich ist, wirkt, und einen oder mehrere Zuckerester einer Speisefettsäure (E 473) in Kombination mit mindestens einem Bestandteil, welcher Träger mindestens einer OH-Gruppe ist, insbesondere Wasser und/oder Ethanol und/oder Glycerin, enthält. The invention provides a composition having an HLB value greater than 10, which acts as an emulsifier for a solubilizate of at least one raw and / or active substance which is not or only sparingly soluble in water, and one or more sugar esters of a fatty acid (E 473) in combination with at least one constituent which is a carrier of at least one OH group, in particular water and / or ethanol and / or glycerol.
Insbesondere kann die Zusammensetzung aus einem oder mehreren Zuckerestern einer Speisefettsäure (E 473) und mindestens einem Bestandteil, welcher Träger mindestens einer OH-Gruppe ist, insbesondere Wasser und/oder Ethanol und/oder Glycerin, bestehen.  In particular, the composition may consist of one or more sugar esters of a fatty acid fatty acid (E 473) and at least one constituent which is a carrier of at least one OH group, in particular water and / or ethanol and / or glycerol.
Die Erfindung stellt ferner ein Solubilisat zur Verfügung, welches zumindest einen Roh- und/oder Wirkstoff enthält, welcher in Wasser nicht oder nur schwer löslich ist, wobei der Roh- und/oder Wirkstoff insbesondere aus der Groppe ausgewählt ist, welche die Vitamine A, D, E und K, The invention further provides a solubilizate which contains at least one raw and / or active substance which is insoluble or sparingly soluble in water, the raw and / or active substance being selected in particular from the coarse containing the vitamins A, D, E and K,
Carotinoide, Flavonoide, Omega-3 -Fettsäuren, Enzyme, Co- Enzyme, Farbstoffe, Pflanzenextrakte, 237 Carotenoids, flavonoids, omega-3 fatty acids, enzymes, coenzymes, dyes, plant extracts, 237
8  8th
Sekundärpflanzenstoffe ( Isoflavone ) , Polyphenole, Secondary plant substances (isoflavones), polyphenols,
ätherische Öle und Antioxidantien wie Alpha-Lipon-Säure und/oder Karnosolsäure und Quercetin umfaßt, und wobei das Solubilisat zumindest eine oben beschriebene, als Emulgator wirkende Zusammensetzung enthält. Das Solubilisat kann insbesondere aus dem zumindest einen Roh- und/oder essential oils and antioxidants such as alpha-lipoic acid and / or carnosic acid and quercetin, and wherein the solubilizate contains at least one emulsifier-acting composition described above. The solubilizate can in particular from the at least one raw and / or
Wirkstoff, welcher in Wasser nicht oder nur schwer löslich ist, wobei der Roh- und/oder Wirkstoff insbesondere aus der Groppe ausgewählt ist, welche die Vitamine A, D, E und K, Carotinoide, Flavonoide, Omega-3-Fettsäuren, Enzyme, Co- Enzyme, Farbstoffe, Pflanzenextrakte, Active substance which is insoluble or sparingly soluble in water, the raw and / or active substance being selected in particular from the coarse containing vitamins A, D, E and K, carotenoids, flavonoids, omega-3 fatty acids, enzymes, Coenzymes, dyes, plant extracts,
Sekundärpflanzenstoffe ( Isoflavone ) , Polyphenole, ätherische Öle und Antioxidantien wie Alpha-Lipon-Säure und/oder Karnosolsäure und Quercetin umfaßt, und der zumindest einen, oben beschriebenen als Emulgator wirkenden Zusammensetzung bestehen. Secondary plant materials (isoflavones), polyphenols, essential oils and antioxidants such as alpha-lipoic acid and / or carnosic acid and quercetin, and at least one, as described above acting as an emulsifier composition.
Geeignete Zusammensetzungen, die als Emulgator wirken, sind beispielsweise die Folgenden, wobei in Prozent (%) der jeweilige Gewichtsanteil angegeben ist: Suitable compositions which act as emulsifier are, for example, the following, wherein in percent (%) the respective weight fraction is indicated:
Emulgatorzusammensetzung A Emulsifier Composition A
Emulgatorzusammensetzung B Emulsifier Composition B
Menge in g  Quantity in g
660 Zuckerester aus Speisefettsäuren (E473), davon  660 sugar esters of fatty acids (E473), thereof
41 % Sucrose-mono-Laurat  41% sucrose mono-laurate
32 % Sucrose-mono-Palmitat  32% sucrose-mono-palmitate
9,0 % Sucrose-di-Laurat  9.0% sucrose-di-laurate
8,5 % Sucrose-di-Palmitat  8.5% sucrose di palmitate
7,0 % Sucrose-mono-Sterat  7.0% sucrose mono-sterate
2,5 % Sucrose-di-Stearat  2.5% sucrose di-stearate
340 Ethanol 96 %ig 340% ethanol 96%
EmulgatorZusammensetzung C Emulsifier composition C
Zur Herstellung der Emulgatorzusammensetzungen werden alle Komponenten bei Raumtemperatur zusammen gemischt, gut verrührt und dabei homogenisiert. Zur Unterstützung kann eine leichte Erwärmung auf beispielsweise etwa 48°C bis 52 °C durchgeführt werden. To prepare the emulsifier compositions, all components are mixed together at room temperature, stirred well and thereby homogenized. For support, a slight warming to, for example, about 48 ° C to 52 ° C can be performed.
4. ) Ausführungsbeispiele für Solubilisate von diversen Roh- und Wirkstoffen unter Einsatz von Emulgator A und/oder B und/oder C 4.) Exemplary embodiments of solubilizates of various raw materials and active ingredients using emulsifier A and / or B and / or C.
In den Rezepturen wird für die Inhaltsstoffe jeweils eine AGT-Material-Nr . angegeben. Dabei handelt es sich um eine Prüfnummer, die der Anmelder für jede verwendete Substanz vergibt und anhand der sich die Identität der jeweils verwendeten Zutat für das Solubilisat zurückverfolgen läßt Für diese Solubilisate wurden zum Teil die In the formulations, an AGT material no. specified. This is a test number that assigns the applicant for each substance used and on the basis of which the identity of the ingredient used in each case for the solubilizate can be traced. For these solubilisates were partially the
Partikelgrößenverteilungen gemessen und die Trübung bestimmt . 4.1 A Particle size distributions measured and the turbidity determined. 4.1 A
4.2 A 4.2 A
4.3 A 4.3 A
4.4 A 4.4 A
4.5A 4.5A
4.6A 4.6A
4.7A 4.7A
4.8A 4.8A
4.9A 4.9A
Trübung liegt hier bei ca. 8 FNU Haze is here at about 8 FNU
4.9 B 4.9 B
AQUANOVA Rezeptur AQUANOVA recipe
Vorgabe BM: 14.08.2009  Default BM: 14.08.2009
Erstelldatum: 17.08.2009 Date of creation: 17.08.2009
Ersetzt Rezeptur vom: Replaces recipe from:
Neuerstellung rebuilding
AGT Nr. : 5020-05H AGT No .: 5020-05H
Bezeichnung: NovaSOL® E Designation: NovaSOL ® E
Wasser- und fettlösliches 20%iges Vitamin E-Actetat- Solubilisat (mit Emulgator B)  Water and fat soluble 20% Vitamin E-Actetate Solubilisate (with Emulsifier B)
Zutaten: Ingredients:
215,2 g Vitamin E-Acetat _ DL-a-Tocopherol-Acetat ; BASF 215.2 g vitamin E acetate _ DL-a-tocopherol acetate; BASF
(AGT-Material-Nr . : 10721/005)  (AGT Material No.: 10721/005)
6,4 g DL-a-Tocopherol , BASF 6.4 g of DL-α-tocopherol, BASF
(AGT-Material Nr.: 10711/005)  (AGT Material No .: 10711/005)
778,4 g Emulgator B 778.4 g emulsifier B
Durchführung : Execution :
- Emulgator auf 65 - 70 °C erwärmen  - Heat the emulsifier to 65 - 70 ° C
- Beide Vitamin E-Komponenten unter Rühren einarbeiten und alles gut homogenisieren (78 - 80 °C)  - Incorporate both vitamin E components with stirring and homogenize well (78 - 80 ° C)
- - Abkühlen (kleiner oder gleich 60 °C) und abfüllen  - - Cool down (less than or equal to 60 ° C) and fill
Ausehen: Gelb, transparent, viskos 4.10 B Look: Yellow, transparent, viscous 4.10 B
AQUANOVA Rezeptur AQUANOVA recipe
EW-Nr. : EW0127/2/H  EW-No. : EW0127 / 2 / H
Bezeichnung : Wasser- und fettlösliches Solubilisat für Vitamin A, D, E und K (in Kombination) (nach DGE- Empfehlungen) Zutaten: Name: Water and fat soluble solubilisate for vitamins A, D, E and K (in combination) (according to DGE recommendations) Ingredients:
784,44g Emulgator B 784.44g emulsifier B
197 g Vitamin E-Acetat = DL-ot-Tocopherol-Acetat ; BASF  197 g vitamin E acetate = DL-ot-tocopherol acetate; BASF
(AGT-Material-Nr . : 10721/005), entspricht 132,5 g Tocopherol-Äquivalenten (TE = aktives Vitamin E) (AGT Material No.: 10721/005), corresponds to 132.5 g of tocopherol equivalents (TE = active vitamin E)
=> durch 8 = 16,5 g TE => through 8 = 16.5 g TE
16,2 g Retinolpalmitat , 1,7 Mio. I.E./g, ölig; BASF, 16.2 g of retinol palmitate, 1.7 million I.U./g, oily; BASF,
(AGT-Nr. : 10700/005) (=8,85 g Retinol bzw.  (AGT No.: 10700/005) (= 8.85 g of retinol or
Retinoläquivalent (RE) , => durch 8 = 1,1 g = 3,67 Mio. I.E.)  Retinol equivalent (RE), => by 8 = 1.1 g = 3.67 million I.U.)
0,6 g Vitamin Kl (Synonyme: 2 -methyl- 1 , 4 -naphtoquinone oder Phyllochinon) (AGT-Material-Nr. : 10760/070) => 0,6 g durch 8 = 0,075 g  0.6 g of vitamin KI (synonyms: 2-methyl-1,4-naphthoquinone or phylloquinone) (AGT Material No.: 10760/070) => 0.6 g by 8 = 0.075 g
1,76 g Vitamin D3 ; Colecalciferol , ölig; 1 mio. I.E./g.; 1.76 g vitamin D3; Colecalciferol, oily; 1 million I.E./g .;
Brenntag/DSM (AGT-Nr. : 10750/037) (=44 mg Vitamin Brenntag / DSM (AGT No.: 10750/037) (= 44 mg of vitamin
D3 => durch 8 = 5,5 mg Vitamin D3 = 220000IE) D3 => by 8 = 5.5 mg vitamin D3 = 220000IE)
Durchführung : Execution :
- Emulgator B erwärmen auf 68 - 72 °C  - Heat emulsifier B to 68 - 72 ° C
- In separatem Gefäß Vitamin E-Acetat erwärmen auf 50 - - In separate jar, heat vitamin E acetate to 50 -
60 °C 60 ° C
- Die einzelnen Vitamine A, D und K zum Vitamin E-Acetat geben, unter Rühren gut einarbeiten und alles sehr gut homogenisieren - es ist darauf zu achten, dass keine Reste am Rand des Gefäßes haften bleiben (50 - 60 °C) - Diese Vitaminmischung in den vorgewärmten Emulgator B einarbeiten und alles sehr gut homogenisieren (70 - 80 °C) . Gegebenenfalls einen kleinen Anteil des - Add the individual vitamins A, D and K to the vitamin E acetate, stir well with stirring and do everything very well homogenize - care must be taken that no residues stick to the edge of the vessel (50 - 60 ° C) - incorporate this vitamin mixture in the preheated emulsifier B and homogenize everything very well (70 - 80 ° C). If necessary, a small portion of the
Emulgators separieren und damit das Gefäß mit der Vitaminmischung nach dessen Entleeren ausschwenken, um eine Überführung der kompletten Vitaminmischung zu gewährleisten  Separate emulsifier and thus swing out the vessel with the vitamin mixture after emptying to ensure a transfer of the complete vitamin mixture
- Abkühlen und bei kleiner oder gleich 60 °C abfüllen  - Cool down and fill at less than or equal to 60 ° C
4.11 (mit Polysorbat) 4.11 (with polysorbate)
AQUA OVA Rezeptur AQUA OVA recipe
Vorgabe BM : 24.01.2006  Default BM: 24.01.2006
Erstelldatum: 04.02.20096 Date of creation: 04.02.20096
Ersetzt Rezeptur vom: Replaces recipe from:
02.11.2006 02.11.2006
EW-Nr. : EW0114/1 EW-No. : EW0114 / 1
Bezeichnung : NovaSOL® D Wasser- und fettlösliches Vitamin D3-Solubilisat Name: NovaSOL ® D Water and fat soluble vitamin D3 solubilisate
Zutaten: Ingredients:
110 g Vitamin D3 ; ölig - Cholecalciferol , ; 1 Mio.  110 g of vitamin D3; oily - cholecalciferol,; 1 million
I.E./g.; Brenntag/DSM (AGT-Nr.: 10750/037)  I.E./g .; Brenntag / DSM (AGT No .: 10750/037)
890 g Polysorbat 80; Crillet 4, CRODA oder Lamesorb SMO 20; Cognis (AGT-Material-Nr . : 10530/111 oder /016) Durchführung : 890 g polysorbate 80; Crillet 4, CRODA or Lamesorb SMO 20; Cognis (AGT Material No.: 10530/111 or / 016) Execution :
- Polysorbat 80 und Vitamin D3 etwas vorwärmen (ca.  - Preheat polysorbate 80 and vitamin D3 a little bit (approx.
70 °C) , zur besseren Fließfähigkeit  70 ° C) for better flowability
- Unter ständigem Rühren Vitamin D ins Polysorbat einarbeiten, alles gut erhitzen (85 - 90 °C) und homogenisieren  - Add vitamin D to the polysorbate with constant stirring, heat well (85 - 90 ° C) and homogenize
- Abkühlen lassen und bei <60 °C abfüllen  - Allow to cool and fill at <60 ° C
Aussehen : Hellgelb, viskos Appearance: pale yellow, viscous
4.1 C 4.1 C
4.2C 4.2C
4.3 C 4.3 C
4.4 C 4.4 C
4.5 C 4.5 C
4.6 C 4.6 C
Alle unter Punkt 4.) genannten Solubilisate (Proben) ergeben, nach einer Erwärmung auf ca. 60 °C und Zugabe ins Wasser mit Raumtemperatur, auch bei vielfacher All solubilisates (samples) mentioned in point 4.), after heating to about 60 ° C and adding to room temperature water, even at multiple
Tagesdosierung der darin enthaltenen Roh- bzw. Wirkstoffe, eine kristallklare und thermisch-, mechanisch- und pH-stabile Daily dosage of the raw materials or active substances contained therein, a crystal-clear and thermally, mechanically and pH-stable
Lösung . Solution.
5. ) Trübungsmessungen : 5.) Turbidity measurements:
Auch bei einer vielfachen Tagesdosierung der beteiligten Mikronährstoffe z. B. in einem Liter Getränk liegt die Trübung der Lösung, auf einer Skala zwischen 0,0 bis 2000, unter 100 FNU bzw. in einigen Fällen sogar unter 5 FNU und somit mit der Klarheit eines reinen Trink- oder Even with a multiple daily dosage of micronutrients involved z. B. in one liter of beverage is the turbidity of the solution, on a scale between 0.0 to 2000, below 100 FNU or in some cases even below 5 FNU and thus with the clarity of a pure drinking or
Mineralwassers vergleichbar. Mineral water comparable.
Trübungsversuchsreiche nach ISO 7027 / EN 27027 Turbidity-rich according to ISO 7027 / EN 27027
Mess-Skala: 0,00 bis 2000,00 FNU Measuring scale: 0.00 to 2000.00 FNU
Nr. Beispiel / Probe Verdünnung in Ergebnis FNU No. Example / sample dilution in result FNU
1000g Getränk  1000g drink
5.1 A 5% Vitamin A 500 mg 22,0  5.1 A 5% Vitamin A 500 mg 22.0
5.2 A 5% Vitamin D3 1 mg 0,2  5.2 A 5% Vitamin D3 1 mg 0.2
5.3 A 5% Vitamin E-Acetat 5 g 54,0  5.3 A 5% Vitamin E acetate 5 g 54.0
5.4 A 5% -Liponsäure 8 g 76,0  5.4 A 5% lipoic acid 8 g 76.0
5.5 A 5% Ubichinon (Q10) Siehe Position 5.6 Siehe Pos. 5.6  5.5 A 5% Ubiquinone (Q10) See item 5.6 See item 5.6
1 9 17,5  1 9 17.5
5.6 A 4,2% Ubichinon(Q10) 6 g 18,6  5.6 A 4.2% ubiquinone (Q10) 6 g 18.6
4,2% Vitamin E- Acetat  4.2% vitamin E acetate
5.7 A 5% Omega-3- 5 g 65,0  5.7 A 5% Omega-3 - 5 g 65.0
Fettsäuren  fatty acids
5.8 A 3% Lutein 1 g 78.0  5.8 A 3% Lutein 1 g 78.0
5.9 A 1 % Apocarotenal 0,5 g 8,0  5.9 A 1% Apocarotenal 0.5 g 8.0
5.9 B 20% Vitamin A- 1 ,25 g 0,6  5.9 B 20% Vitamin A-1, 25 g 0.6
Acetat  acetate
5.10 B Vitamin-Kombination g < 0,1  5.10 B Vitamin combination g <0.1
aus A, D, E und K (s.  from A, D, E and K (s.
Rezeptur)  recipe)
5.1 1 10% Vitamin D3 0,5 mg < 0,1  5.1 1 10% Vitamin D3 0.5 mg <0.1
5.1 C 5% Vitamin A 500 mg 9,5  5.1 C 5% Vitamin A 500 mg 9.5
5.2 C 5% Vitamin D3 1 mg < 0, 1  5.2 C 5% Vitamin D3 1 mg <0, 1
5.3 C 5% Vitamin E-Acetat 5 g < 0, 1  5.3 C 5% Vitamin E acetate 5 g <0, 1
5.4 C 5% a-Liponsäure 8 g 17,1  5.4 C 5% α-lipoic acid 8 g 17.1
5.5 C 5% Ubichinon (Q10) i g 47,0  5.5 C 5% ubiquinone (Q10) i g 47.0
5.6 C 3% Lutein 1 g 36 6.) Stabilität: 5.6 C 3% lutein 1 g 36 6.) Stability:
Um einerseits die Stabilität der Micelle und andererseits die einheitliche Micellenstruktur in ihrer Größe (nm) zu zeigen, wurde aus den vielen Ausführungsbeispielen der Solubilisate bewusst ein Solubilisat mit komplexer Kombination von 4 fettlöslichen Vitaminen (A, D, E + K) untersucht . Um die Stabilität zu demonstrieren wurde in der Lösung, in der die besagten Vitamin-Micellen enthalten sind, der pH- Wert von 1,1 (Magensäure) und eine Temperatur von 37° C (Körpertemperatur) gewählt. Der mittlere Durchmesser der Micelle (sieht man von analytisch bedingten Messtolleranzen ab) liegt bei 11 nm. On the one hand to show the stability of the micelle and on the other hand the uniform micelle structure in size (nm), a solubilizate with a complex combination of 4 fat-soluble vitamins (A, D, E + K) was deliberately investigated from the many embodiments of the solubilisate. In order to demonstrate stability, in the solution containing said vitamin micelles, the pH of 1.1 (gastric acid) and a temperature of 37 ° C (body temperature) were chosen. The mean diameter of the micelle (apart from analytically determined measurement tolerances) is 11 nm.
Die Partikelgrößenmessungen wurden mit dem ParticleMetrix NANOTRAC Rückstreu-Teilchenanalysator durchgeführt. Das Messprinzip beruht auf der dynamischen Lichtstreuung (DLS) in einer 180° Heterodyn-Rückstreuanordnung . Bei dieser Geometrie wird zum gestreuten Licht ein Teil des Particle size measurements were made with the ParticleMetrix NANOTRAC Backscatter Particle Analyzer. The measuring principle is based on dynamic light scattering (DLS) in a 180 ° heterodyne backscatter arrangement. With this geometry, the scattered light becomes part of the
Laserstrahls dazu gemischt. Dies hat denselben positiven Effekt hinsichtlich des Signal/Rausch-Verhältnisses wie die Überlagerung aller Lichtwellenlängen in einem Fourier- Spektrometer . In Figur 6 wird das Meßprinzip in einer schematischen Darstellung grafisch verdeutlicht. Laser beam mixed. This has the same positive effect in terms of signal-to-noise ratio as the superposition of all wavelengths of light in a Fourier spectrometer. In Figure 6, the measuring principle is graphically illustrated in a schematic representation.
Das Laserlicht einer Wellenlänge von 780 nm wird auf der einen Seite einer Lichtfasergabel eingekoppelt: The laser light of a wavelength of 780 nm is coupled on one side of a light fiber fork:
Eingestrahltes Licht (41) . Zurück kommt in derselben Faser der Anteil des an der Glaswand des Meßbehälters  Inhaled light (41). Back comes in the same fiber, the proportion of the glass wall of the measuring container
reflektierten Laserlichts, zusammen eingestrahltes und reflektiertes Licht (42) und das von der Probe rückwärts gestreute Licht (43) . Beides teilt sich gleichmäßig auf die beiden Lichtleiteräste auf. Im Detektor (60) des zweiten Astes der Lichtleitergabel wird das gemischte Licht, das gestreute und reflektierte Licht (44) registriert. Diereflected laser light, irradiated together and reflected light (42) and the backscattered light (43) from the sample. Both split evenly on the two light guide branches. In the detector (60) of the second branch of the optical fiber fork, the mixed light, the scattered and reflected light (44) is registered. The
Fluktuation des Signals, das durch die Brown' sehe Bewegung im Streulicht und damit im Gesamtsignal ergibt, wird über die Stokes-Einstein-Beziehung und eine schnelle Fourier- Analyse in eine Partikelgrößenverteilung umgerechnet. Die Farbe der Probe hat keinen Einfluss auf die Qualität derFluctuation of the signal resulting from the Brown's motion in the scattered light and thus in the overall signal is converted into a particle size distribution via the Stokes-Einstein relationship and a fast Fourier analysis. The color of the sample does not affect the quality of the sample
Messung. Der detektierbare Partikelgrößenbereich erstreckt sich von 0,8 nm bis 6500 nm. Die Messungen wurden in lOOOfacher wäßriger Verdünnung durchgeführt. Das Measurement. The detectable particle size range extends from 0.8 nm to 6500 nm. The measurements were carried out in 1000 times the aqueous dilution. The
Solubilisat wurde dazu unter Rühren in Wasser gelöst. Es ist vollständig klar in Wasser löslich. Diese Lösung ist stabil, transparent. Solubilisate was dissolved with stirring in water. It is completely soluble in water. This solution is stable, transparent.
Die Trübung einer Probe beruht darauf, dass einfallendes Licht an den suspendierten Teilchen von ungelöste, fein verteilten Substanzen gestreut wird. Trifft ein gerader Lichtstrahl auf diese Partikel (50) , so wird das Licht in alle Richtungen gestreut. Zur Trübungsmessung wurde eine Streulichtmessung mit Infrarotlicht durchgeführt. Bei geringen Trübungswerten kann von einer geringen Anzahl von ungelösten Inhaltsstoffen ausgegangen werden. The turbidity of a sample is due to the fact that incident light is scattered on the suspended particles of undissolved, finely divided substances. If a straight light beam strikes these particles (50), the light is scattered in all directions. For turbidity measurement, a scattered light measurement was carried out with infrared light. At low turbidity levels, a small number of undissolved ingredients can be assumed.
Ein Analysereport der ParticleMetrix GmbH zu den Messungen nach dem Prinzip „Nanotrac" wurde zusammen mit der An analysis report of the ParticleMetrix GmbH on the measurements according to the principle "Nanotrac" was together with the
Anmeldung zur Akte gereicht. Registration filed.
Es ist dem Fachmann ersichtlich, dass die Erfindung nicht auf die vorstehend beschriebenen Ausführungsbeispiele beschränkt ist, sondern vielmehr in vielfältiger Weise variiert werden kann. Insbesondere können die Merkmale der einzelnen Ausführungsbeispiele auch miteinander kombiniert oder gegeneinander ausgetauscht werden. It will be apparent to those skilled in the art that the invention is not limited to the embodiments described above, but rather in many ways can be varied. In particular, the features of the individual embodiments can also be combined or replaced with each other.

Claims

Zusammensetzung mit einem HLB-Wert von größer 10, welche als Emulgator für ein Solubilisat zumindest eines Roh- und/oder Wirkstoffes, welcher in Wasser nicht oder nur schwer löslich ist, wirkt, und einen oder mehrere Zuckerester einer Speisefettsäure (E 473) in Kombination mit mindestens einem A composition having an HLB value of greater than 10, which acts as an emulsifier for a solubilizate of at least one crude and / or active substance which is sparingly or sparingly soluble in water, and one or more sugar esters of a fatty acid (E 473) in combination with at least one
Bestandteil, welcher Träger mindestens einer OH- Gruppe ist, insbesondere Wasser und/oder Ethanol und/oder Glycerin, enthält. Component which carrier is at least one OH group, in particular water and / or ethanol and / or glycerol contains.
Zusammensetzung nach Anspruch 1, bei welchem der zumindest eine Zuckerester von Speisefettsäuren aus der Gruppe ausgewählt ist, welche Sucrose-mono- Laurat, Sucrose-di-Laurat , Sucrose-mono- Palmitat , Sucrose-di-Palmitat , Sucrose-mono-Stearat und A composition according to claim 1, wherein the at least one sugar ester of fatty acids is selected from the group consisting of sucrose mono-laurate, sucrose-di-laurate, sucrose-mono-palmitate, sucrose-di-palmitate, sucrose-mono-stearate and
Sucrose-di-Stearat umfaßt. Sucrose-di-stearate.
Zusammensetzung nach Anspruch 1 oder 2, bei welcher der als Emulgator wirksamen Kombination aus A composition according to claim 1 or 2, wherein the combination of effective emulsifier
zumindest einem Zuckerester aus Speisefettsäuren und einem Träger mindestens einer OH-Gruppe des Weiteren zumindest ein mittelkettiges Triglycerid (medium chain triglyceride , MCT) beigegeben ist. at least one sugar ester of fatty acids and a carrier of at least one OH group of further at least one medium-chain triglyceride (medium chain triglycerides, MCT) is added.
Micellenbildende , insbesondere polysorbat- und lecitinfreie , Emulgatorzusammensetzung , Micelle-forming, in particular polysorbate- and lecitin-free, emulsifier composition,
insbesondere nach einem der Ansprüche 1 bis 3 , zur Solubilisierung hydrophober Roh- und/oder  in particular according to one of claims 1 to 3, for the solubilization of hydrophobic raw and / or
Wirkstoffe zur homogenen und stabilen  Active ingredients for homogeneous and stable
Anreicherung von Lebensmitteln, insbesondere von klaren Getränken und/oder flüssigen Enrichment of food, in particular of clear drinks and / or liquid
Nahrungsergänzüngsmitteln, mit hydrophoben Dietary supplements, with hydrophobic
Mikronährstoffen, enthaltend eine Kombination von Zuckerester von Speisefettsäuren (E 473) mit einem j HLB-Wert von größer 10 wie Micronutrients containing a combination of sugar esters of fatty acids (E 473) with an HLB value greater than 10 such as
a) Sucrose -mono-Palmitat C28 H52 O12 b) Sucrose -mono-Stearat C 4 H82 O13 c) Sucrose -mono-Laurat C2 H44 0 12 a) sucrose mono-palmitate C28 H52 O12 b) sucrose mono-stearate C4 H82 O13 c) sucrose mono-laurate C 2 H44 O 12
d) Sucrose -di-Laurat c36 HG6 O13 sowie Hilfsstoffe: e) Glycerol d) sucrose -di-laurate c 36 HG6 O13 and adjuvants: e) glycerol
f) Ethanol  f) ethanol
g) Wasser und  g) water and
h) mittelkettige Triglyceride (MCT)  h) Medium Chain Triglycerides (MCT)
Micellenbildende , insbesondere polysorbat- und lecitinfreie , Emulgatorzusammensetzung, Micelle-forming, in particular polysorbate- and lecitin-free, emulsifier composition,
insbesondere nach einem der Ansprüche 1 bis 3 , zur Solubilisierung hydrophober Roh- und/oder in particular according to one of claims 1 to 3, for the solubilization of hydrophobic raw and / or
Wirkstoffe zur homogenen und stabilen Active ingredients for homogeneous and stable
Anreicherung von Lebensmitteln, insbesondere von klaren Getränken und/oder flüssigen Enrichment of foods, especially clear drinks and / or liquid
Nahrungsergänzüngsmitteln, mit hydrophoben Dietary supplements, with hydrophobic
Mikronährstoffen, enthaltend eine Kombination von Zuckerester von Speisefettsäuren (E 473) mit einem HLB-Wert von größer 10 wie a) Sucrose -mono-Laurat C24 H44 0 12 Micronutrients containing a combination of sugar esters of fatty acids (E 473) with an HLB value of greater than 10 such as a) sucrose mono-laurate C 2 H 44 0 12
b) Sucrose -mono-Palmitat C28 H52 0l2 c) Sucrose -di-Laurat c36 Ηβ6 o13 d) Sucrose -di-Palmitat C4 Ηδ2 O13 e) Sucrose-mono-Stearat C30 H56 Oi2 f ) Sucrose-di-Stearat Cs H90 Oi3 sowie Hilfsstoff: g) Ethanol b) sucrose-mono-palmitate C28 H52 0l2 c) sucrose -di-laurate c 36 Ηβ6 o 13 d) sucrose -di-palmitate C4 Ηδ2 O13 e) sucrose mono-stearate C 30 H 56 Oi 2 f) sucrose di-stearate Cs H 90 O i3 and adjuvant: g) ethanol
Micellenbildende , insbesondere polysorbat- und lecitinfreie , Emulgatorzusammensetzung , Micelle-forming, in particular polysorbate- and lecitin-free, emulsifier composition,
insbesondere nach einem der Ansprüche 1 bis 3 , zur Solubilisierung hydrophober Roh- und/oder in particular according to one of claims 1 to 3, for the solubilization of hydrophobic raw and / or
Wirkstoffe zur homogenen und stabilen Active ingredients for homogeneous and stable
Anreicherung von Lebensmitteln, insbesondere von klaren Getränken und/oder flüssigen Enrichment of foods, especially clear drinks and / or liquid
Nahrungsergänzüngsmitteln, mit hydrophoben Dietary supplements, with hydrophobic
Mikronährstoffen, enthaltend eine Kombination von Zuckerester von Speisefettsäuren (E 473) mit einem HLB-Wert von größer 10 wie Micronutrients containing a combination of sugar esters of fatty acids (E 473) with an HLB value greater than 10 such as
C) Kombination von A) und B) C) Combination of A) and B)
Solubilisat, welches zumindest einen Roh- und/oder Wirkstoff enthält, welcher in Wasser nicht oder nur schwer löslich ist, Solubilisat, which contains at least one raw and / or active substance which is not or only slightly soluble in water,
wobei der Roh- und/oder Wirkstoff  wherein the raw and / or active ingredient
insbesondere aus der Groppe ausgewählt ist, welche die Vitamine A, D, E und K, Carotinoide, Flavonoide, Omega-3 -Fettsäuren, Enzyme, Co- Enzyme, Farbstoffe, Pflanzenextrakte, is selected in particular from the coarse containing vitamins A, D, E and K, carotenoids, flavonoids, omega-3 fatty acids, enzymes, coenzymes, dyes, plant extracts,
Sekundärpflanzenstoffe ( Isoflavone ) , Secondary plant substances (isoflavones),
Polyphenole, ätherische Öle und Antioxidantien wie Alpha-Lipon-Säure und/oder Karnosolsäure und Quercetin umfaßt, und wobei das Solubilisat zumindest eine als Emulgator wirkende Zusammensetzung nach einem der vorangegangenen Ansprüche enthält . Including polyphenols, essential oils and antioxidants such as alpha-lipoic acid and / or carnosic acid and quercetin, and wherein the solubilizate contains at least one composition acting as an emulsifier according to any one of the preceding claims.
Wasserlösliches Solubilisat nach Anspruch 7 sowie gemäß den Ausführungsbeispielen 4.1 A bis 4.9 B sowie 4.10 B und 4.1 C bis 4.6 C mit einer Konzentration von den darin enthaltenen Roh- und Wirkstoffen bis 20% sowie enthaltend micellenbildende Emulgatorzusammensetzung gemäß den vorangegangenen Ansprüchen . A water-soluble solubilizate according to claim 7 and according to the working examples 4.1 A to 4.9 B and 4.10 B and 4.1 C to 4.6 C with a concentration of the raw materials and active substances contained therein of up to 20% and containing micelle-forming emulsifier composition according to the preceding claims.
Wasserlösliches Solubilisat von Mikronährstoffen nach den vorangeganenen Ansprüchen sowie gemäß den Ausführungsbeispielen 4.1 A bis 4.9 B sowie 4.10 B und 4.1 C bis 4.6 C, enthaltend micellenbildende Emulgatorzusammensetzung nach einem der vorangegangenen Ansprüche. Soluble water solubilisate of micronutrients according to the preceding claims and according to the embodiments 4.1 A to 4.9 B and 4.10 B and 4.1 C to 4.6 C, containing micelle-forming emulsifier according to any one of the preceding claims.
Wasserlösliches Solubilisat nach einem der vorangegangenen Ansprüche enthaltend fettlösliche, bzw. hydrophobe Roh- und Wirkstoffe der Gruppen Water-soluble solubilisate according to one of the preceding claims containing fat-soluble or hydrophobic raw materials and active ingredients of the groups
Vitamine (fettlösliche) : A, D, E und K Vitamins (fat-soluble): A, D, E and K
Carotinoide: Betacarotin, Curcumin, Lutein carotenoids: beta carotene, curcumin, lutein
■ Flavonoide: Quercetin,  ■ flavonoids: quercetin,
Rutin  rutin
Enzyme / Co-Enzyme (fettlösliche) : Q10 enzymes / co-enzymes (fat-soluble): Q10
Farbstoffe (hydrophobe) : Apocarotenal , Paprikaextrakt Pflanzenextrakte: Dyes (hydrophobic): apocarotenal, paprika extract Plant extracts:
Rosmarinextrakt , Traubenkernextrakt Rosemary extract, grape seed extract
Polyphenole : Resveratrol Polyphenols: Resveratrol
Ätherische Öle: Orangenöl, Essential oils: orange oil,
Citral  Citral
Antioxidantien: Antioxidants:
Mischtocopherole  mixed tocopherols
Omega- 3 -Fettsäuren Omega-3 fatty acids
Flüssiges Lebens- und Nahrungsergänzungsmittel enthaltend micellenbildende Liquid food and nutritional supplement containing micelle-forming
Emulgatorzusammensetzung und wasserlösliche  Emulsifier composition and water-soluble
Solubilisate nach Ansprüchen 1 bis 4.  Solubilisates according to claims 1 to 4.
Flüssiges Produkt nach einem der vorangegangenen Ansprüche dadurch gekennzeichnet, dass die darin enthaltenen hydrophoben Roh- und Wirkstoffe in gleichmäßigen micellaren Strukturen vorliegen und daher eine optimale thermische, mechanische und pH-Stabilität sowie Transparenz aufweisen. Liquid product according to one of the preceding claims, characterized in that the hydrophobic raw materials and active substances contained therein are present in uniform micellar structures and therefore have optimum thermal, mechanical and pH stability as well as transparency.
Wasserlösliches Solubilisat nach einem der vorangegangenen Ansprüche mit einer Konzentration von den darin enthaltenen Roh- und Wirkstoffen zwischen 0,5 und 25 Gew.-%. Water-soluble solubilisate according to one of the preceding claims with a concentration of the raw materials and active substances contained therein between 0.5 and 25 wt .-%.
14. Wasserlösliche Solubilisate nach einem der 14. Water-soluble solubilisates according to one of
vorangegangenen Ansprüchen für die Anwendung im Bereich von Lebensmitten,  previous claims for use in the field of food,
Nahrungsergänzüngsmitteln, Kosmetika,  Nutritional supplements, cosmetics,
Pflegemittel und Pharmazeutik .  Care products and pharmaceuticals.
EP10785350A 2009-12-01 2010-11-30 Composition acting as an emulsifier for water-soluble solubilisates of hydrophobic compounds Withdrawn EP2506726A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE202009016292U DE202009016292U1 (en) 2009-12-01 2009-12-01 Emulsifying composition for water-soluble solubilisates of hydrophobic compounds
PCT/EP2010/007237 WO2011066937A1 (en) 2009-12-01 2010-11-30 Composition acting as an emulsifier for water-soluble solubilisates of hydrophobic compounds

Publications (1)

Publication Number Publication Date
EP2506726A1 true EP2506726A1 (en) 2012-10-10

Family

ID=43498787

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10785350A Withdrawn EP2506726A1 (en) 2009-12-01 2010-11-30 Composition acting as an emulsifier for water-soluble solubilisates of hydrophobic compounds

Country Status (3)

Country Link
EP (1) EP2506726A1 (en)
DE (1) DE202009016292U1 (en)
WO (1) WO2011066937A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130004619A1 (en) * 2011-06-28 2013-01-03 Kemin Industries, Inc. Method of Forming Encapsulated Compositions with Enhanced Solubility and Stability
DE202012012130U1 (en) 2012-12-19 2014-03-21 Aquanova Ag Curcuminsolubilisat
DE102013017165A1 (en) 2013-10-16 2015-04-16 Eberhard Karls Universität Tübingen Medizinische Fakultät Composition for immunomodulation
WO2017215980A1 (en) * 2016-06-14 2017-12-21 Aquanova Ag Resveratrol solubility
DE202019104734U1 (en) * 2019-08-29 2020-12-01 Aquanova Ag Folic acid solubilisate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5525430A (en) * 1978-08-10 1980-02-23 Nippon Saafuakutanto Kogyo Kk Thickening and gelling agent
KR100343664B1 (en) * 1993-12-20 2002-11-27 산에이겐 에후.에후. 아이. 가부시키가이샤 Stable emulsified compositions and foods containing the same
US6140375A (en) * 1996-05-23 2000-10-31 Taisho Pharmaceutical Co., Ltd. Microemulsion
US20080131515A1 (en) * 2006-12-01 2008-06-05 Fujifilm Corporation Emulsion composition, and foods and cosmetics containing the emulsion composition
DK2192160T3 (en) * 2008-12-01 2016-12-12 Aquanova Ag INTEGRATED oxidation of micelles FOR NATURAL DYES
JP5680275B2 (en) * 2009-01-20 2015-03-04 富士フイルム株式会社 Emulsion composition, food and cosmetic containing the emulsion composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MONZER FANUN: "Properties of microemulsions with sugar surfactants and peppermint oil", COLLOID AND POLYMER SCIENCE ; KOLLOID-ZEITSCHRIFT UND ZEITSCHRIFT FÜR POLYMERE, SPRINGER, BERLIN, DE, vol. 287, no. 8, 12 May 2009 (2009-05-12), pages 899 - 910, XP019712796, ISSN: 1435-1536 *

Also Published As

Publication number Publication date
WO2011066937A1 (en) 2011-06-09
DE202009016292U1 (en) 2011-04-07

Similar Documents

Publication Publication Date Title
EP2934185B1 (en) Curcumin solubilisate
Kaimainen et al. Encapsulation of betalain into w/o/w double emulsion and release during in vitro intestinal lipid digestion
Banasaz et al. Encapsulation of lipid-soluble bioactives by nanoemulsions
EP1404291B1 (en) Water-free ubiquinone concentrate
EP2687103B1 (en) Process for manufacturing an aqueous transparent oil-in-water emulsion comprising a carotenoid and emulsion produced
EP0866117A1 (en) Microemulsion
EP1338271B1 (en) Aqeous solution of ascorbic acid
EP2506726A1 (en) Composition acting as an emulsifier for water-soluble solubilisates of hydrophobic compounds
DE102005031467A1 (en) Emulsifier system, emulsion and their use
WO2010063447A2 (en) Micellarly integrated oxidation inhibition for natural colorings
EP3651804A1 (en) Solubilisate with curcumin, boswellia, and xanthohumol
CN103635103A (en) Formulation of transparent and nutritive microemulsions
EP3820529B1 (en) Solubilisate with curcumin and at least the cannabinoid thc as a further active agent
Cerezal Mezquita et al. Isotonic beverage pigmented with water-dispersible emulsion from astaxanthin oleoresin
Zhu et al. Formation and stability of Eucommia ulmoides Oliver seed oil‐loaded inverse microemulsion formed by food‐grade ingredients and its antioxidant activities
Deng et al. Quality by design approach for the preparation of fat-soluble vitamins lipid injectable emulsion
WO2019011415A1 (en) Solubilisate with curcumin, xanthohumol and licorice root extract
JP6667043B1 (en) Microemulsions and the use of microemulsions
JP6622950B1 (en) Compositions for preparing microemulsions, microemulsions, methods for their production and use of microemulsions
Tunit et al. Emulgels containing perilla frutescens seed oil, moringa oleifera seed oil, and mixed seed oil: microemulsion and safety assessment
EP3468607B1 (en) Resveratrol solubility
DE102017115496A1 (en) Licorice root extract Solubilisate
WO2019011414A1 (en) Solubilisate with curcumin and boswellia
Artanti et al. Formulation optimization and antioxidant test for Self-nano emulsifying drug delivery system of soursop leaves (Annona muricata L.) chloroform extract using candlenut oil as oil phase
Yuan Development of microemulsion delivery systems for bioactive compounds: a thesis presented in partial fulfilment of the requirements for the degree of Doctor of Philosophy in Food Technology at Massey University, Auckland, New Zealand

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120530

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20140602

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20160404